跳至主要内容
临床试验/IRCT20220302054167N1
IRCT20220302054167N1已完成3 期

Evaluation of the efficacy of N-acetylcysteine and Bromhexine compared with Standard Care in Preventing Hospitalization of Outpatients with COVID-19: A double-blind randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 225 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Outpatients with Covid-19 symptoms after positive Covid-19 RT-PCR test
  • Oxygen level 98-92%

排除标准

  • Dissatisfaction of the patient or their relatives to participate in the study
  • Pregnancy and lactation
  • Evidence of pulmonary involvement and the need for hospitalization or referral to an infectious disease specialist
  • Prohibition of N-acetylcysteine and bromhexine as a history of allergy and anaphylactic shock

研究者

相似试验

The effect of acetylcysteine and bromhexine on the... | 临床试验